Pitch Competition: Building a Biotech Venture program

Loading Events

web banner

Join us in-person for the Building a Biotech Venture Pitch Competition to learn how the next generation of regenerative and precision medicine researchers are preparing to translate their discoveries toward impact.

Watch as six trainee-led teams from the University of Toronto and its affiliated hospitals pitch their ventures to an expert panel of judges. The winning team will receive $25,000, and the second-place team will receive $10,000 in research funding to advance their product concept.

The competition is the culmination of Medicine by Design’s Building a Biotech Venture program, offered in partnership with the Precision Medicine Initiative (PRiME), Health Innovation Hub (H2i) and Talk Boutique. Over the past several months, teams have worked with mentors to advance early-stage company concepts based on their research and have participated in a series of workshops to develop their business cases.

Come cheer on these up-and-coming entrepreneurs as they showcase their innovative technologies.


ONRamp @ UofT Entrepreneurship
Banting Institute, 100 College St #150,

Meet the judges

Meet the teams

logoCApt Dynamics

Unlocking the potential of nucleic acids in molecular diagnostics and therapeutics.

CApt Dynamics introduces a cutting-edge platform that uses AI and high dimensional medical devices to discover new compounds that can target, diagnose and potentially treat various diseases.

Team members: Armin Geraili, Dingran Chang
The Kelley Lab, Leslie Dan Faculty of Pharmacy, University of Toronto

logoMyoxa Therapeutics

Re-engineered cell therapies for improved transplant success.

Myoxa aims to engineer cell therapies that allow a graft to stay alive in low oxygen settings, which is a major shortcoming in using cell-based grafts for clinical therapy.

Team members: Aanshi Gandhi, Aaron Rosenstein, Mohammad Saleh, Danielle Serra, Maria Nguyen
The Garton Lab, Institute of Biomedical Engineering, University of Toronto


Alleviating pathology, treating neurons.

Neuropeutics’ mission is to ameliorate patients’ lives by prioritizing the advancement of small molecule to the clinic, which prevents toxic clumping of a protein involved in neurodegeneration.

Team members: Marc Shenouda, Namita Multan
The Robertson Lab, Department of Laboratory Medicine & Pathobiology, University of Toronto

logoSpecifix Dx

A point-of-care rapid test that detects urinary tract infections with significantly greater accuracy.

Specifix Dx has developed UroStix, which is a paper-based rapid test that can detect urinary tract infections (UTI) with significantly greater accuracy compared to conventional tools in use today.

Team members: Jessican Jenkins, Siobhan Wilson, Jaspreet Randhawa
The Ferenbok Lab, Department of Laboratory Medicine & Pathobiology, University of Toronto


Screening services for effective formula & treatment discovery.

StemTEST is developing a human stem cell derived skin model combined with AI software to objectively test the efficacy of skin products marketed for reducing hyperpigmentation.

Team members: Henry Quach, Kayshani Kanagarajah, Krista Antonio, Yuetong Song
The Wong Lab, Program of Developmental & Stem Cell Biology, The Hospital for Sick Children

Synakis logoSynakis

Solutions for the eye.

Synakis has developed Syngel, which could replace the natural vitreous in the eye for patients with ocular disorders such as retinal detachment and dry-age-related macular degeneration (AMD).

Team members: Mickael Dang, Adam Forman, Jonathan Labriola
The Shoichet Lab, Institute of Biomedical Engineering, University of Toronto

Share This Story

Go to Top